A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
PHASE3
This is a parallel group, Phase 3, multinational, multicenter, randomized, ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham- Site Number : 8401267
Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis
PHASE4
Atopic dermatitis (AD), commonly known as eczema, is a chronic skin conditi...